Home » Stocks » CV Sciences

CV Sciences, Inc. (CVSI)

Stock Price: $0.643 USD -0.037 (-5.44%)
Updated Aug 7, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 64.20M
Revenue (ttm) 35.60M
Net Income (ttm) n/a
Shares Out 99.85M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE 15.63
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $0.643
Previous Close $0.680
Change ($) -0.037
Change (%) -5.44%
Day's Open 0.635
Day's Range 0.589 - 0.670
Day's Volume 1,578,500
52-Week Range 0.250 - 3.890

More Stats

Market Cap 64.20M
Enterprise Value n/a
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 99.85M
Float 85.62M
EPS (basic) n/a
EPS (diluted) -0.19
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.54
PE Ratio n/a
Forward PE 15.63
P/FCF Ratio n/a
PS Ratio 1.80
PB Ratio 2.67
Revenue 35.60M
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share 0.00
Gross Margin 98.57%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -10.20%
ROE -64.99%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$0.93*
(44.63% upside)
Low
0.60
Current: $0.643
High
1.35
Target: 0.93
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name CV Sciences, Inc.
Country United States
Employees 118
CEO Joseph D. Dowling

Stock Information

Ticker Symbol CVSI
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: CVSI

Description

CV Sciences, Inc. operates as a life science company. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets hemp-based cannabidiol (CBD) products under the name of PlusCBD in a range of market sectors, including nutraceutical, beauty care, and specialty foods. It serves internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, master distributors, specialty retailers, and convenience stores, as well as food, drug, and mass merchandise retailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. Its products product candidates are based on proprietary formulations, processes, and technology. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.